Abbott has secured the US FDA approval for its next generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring.

Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary incontinence (UUI).

Synergy Spine Solutions has received PMA from the FDA for the Synergy Disc, expanding cervical disc replacement options for US patients.

Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant ...

Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.

Academia Sinica and NTU Hospital have jointly developed PanMETAI, an AI metabolomics platform for pancreatic cancer detection in early stages.

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in MASLD.

Knight Therapeutics has announced the regulatory submission of axatilimab in Brazil to treat chronic graft-versus-host disease (cGvHD).

Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer mortality.

GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite workflows.

TECLens has commenced the first-in-human clinical trial assessing its qCXL technology for non-invasive refractive vision correction, administering treatment to the initial patient.

Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions.